<DOC>
	<DOCNO>NCT00831545</DOCNO>
	<brief_summary>The study imply 2 step study design . Patients enrol 3 separate group melanoma , breast , non-small cell lung cancer . In first step , 21 patient per disease group enrol . If &gt; =2 objective response ( SD , PR , CR ) 21 evaluable patient observe , enrollment continue 45 patient whole , response positively evaluate &gt; =10 patient respond . If &lt; 2 objective response 21 evaluable patient per disease group observe , ( ese ) group ( ) longer treat temozolomide .</brief_summary>
	<brief_title>Study Evaluate Efficacy Safety Temozolomide Subjects With Brain Metastases Either Malignant Melanoma , Breast , Non-small Cell Lung Cancer ( P02064 )</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>Cytological/histological diagnosis either melanoma , nonsmall cell lung cancer breast ; Brain metastases &gt; =1 cm present progression follow &gt; =4 week time interval free previous malignancyspecific chemotherapy , hormone therapy , medical therapy ; Magnetic resonance imaging suspect brain metastasis ; patient brain lesion ( ) univocal brain metastasis must negative radiolabeled leukocyte brain scan rule infectious nonmalignant disease ; neuroradiological study ( baseline treatment outcome evaluation ) , except emergency exam must perform 10 day unchanged schedule dexamethasone , obtain axialcoronalsagittal plane T1 T2 gadolinium enhancement . Presence al least one bidimensionally measurable previously irradiate metastasis . Age &lt; =70 year . Performance status 02 ( ECOGWHO scale ) . Blood leukocytes &gt; =3.5 x 10^9/L platelet &gt; =100 x 10^9/L . Bilirubin &lt; =25 M/L . Seric transaminases &lt; =2 x upper limit normal value . Creatinine &lt; =150 M/L , creatinine clearance &gt; =60 mL/min . Signed write informed consent . Diabetes allow administration adequate dos dexamethasone least first 2 month treatment . Previous whole brain irradiation . Brain metastases eligible neurosurgery stereotactic radiation therapy . Previous current malignancy sit exception adequately treat situ carcinoma cervix basal squamous carcinoma skin . Pregnant nursing woman . Acute infection require intravenous antibiotic . Severe vomit medical condition could interfere oral medication intake . Anticonvulsant chronic therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>